When an autonomous clinical pathway agent operates under uncertain model confidence, simulation rehearses how its decisions and escalation behavior change before deployment. It replaces confidence based only on fixed design artifacts with evidence from varied, plausible conditions. section 2.2.3
Simulation treats behavior as probabilistic and context-dependent rather than assuming that all relevant paths can be specified and tested in advance. Its architectural purpose is to explore decision boundaries, escalation thresholds, and behavior under stress—not to prove model accuracy or component correctness. section 2.2.3
Use simulation to:
- Rehearse failure modes and boundary conditions across a range of plausible scenarios. section 2.2.3
- Expose escalation thresholds that permit questionable decisions before authority returns to humans. section 2.2.3 section 2.4
- Support a resilience loop linking autonomy boundaries, observability, policy enforcement, and escalation. section 2.4
Clinical pathway model drift
A clinical pathway agent was tested against gradual confidence degradation from 0.12 to 0.20 to 0.30, sudden degradation from 0.12 to 0.35, and simultaneous drift across multiple models. The simulations showed that a 0.35 escalation threshold was too permissive because questionable decisions had already occurred. Lowering the threshold to 0.30 tightened the autonomy boundary before deployment. section 2.2.3










